Identification of rare-disease genes in diverse undiagnosed cases using whole blood transcriptome sequencing and large control cohorts
Kevin S. Smith,
Nicole M. Ferraro,
Nicole A. Teran,
Kristin D. Kernohan,
Joe R. Davis,
Cameron J. Prybol,
Jennefer N. Kohler,
Diane B. Zastrow,
Dianna G. Fisk,
Megan E. Grove,
Jean M. Davidson,
Benjamin J. Strober,
Care4Rare Canada Consortium,
Undiagnosed Diseases Network,
Jonathan A. Bernstein,
Euan A. Ashley,
Kym M. Boycott,
Jason D. Merker,
Matthew T. Wheeler,
Stephen B. Montgomery
Posted 04 Sep 2018
bioRxiv DOI: 10.1101/408492
Posted 04 Sep 2018
RNA sequencing (RNA-seq) is a complementary approach for Mendelian disease diagnosis for patients in whom exome-sequencing is not informative. For both rare neuromuscular and mitochondrial disorders, its application has improved diagnostic rates. However, the generalizability of this approach to diverse Mendelian diseases has yet to be evaluated. We sequenced whole blood RNA from 56 cases with undiagnosed rare diseases spanning 11 diverse disease categories to evaluate the general application of RNA-seq to Mendelian disease diagnosis. We developed a robust approach to compare rare disease cases to existing large sets of RNA-seq controls (N=1,594 external and N=31 family-based controls) and demonstrated the substantial impacts of gene and variant filtering strategies on disease gene identification when combined with RNA-seq. Across our cohort, we observed that RNA-seq yields a 8.5% diagnostic rate. These diagnoses included diseases where blood would not intuitively reflect evidence of disease. We identified RARS2 as an under-expression outlier containing compound heterozygous pathogenic variants for an individual exhibiting profound global developmental delay, seizures, microcephaly, hypotonia, and progressive scoliosis. We also identified a new splicing junction in KCTD7 for an individual with global developmental delay, loss of milestones, tremors and seizures. Our study provides a broad evaluation of blood RNA-seq for the diagnosis of rare disease.
- Downloaded 2,116 times
- Download rankings, all-time:
- Site-wide: 3,549 out of 94,912
- In genomics: 631 out of 5,955
- Year to date:
- Site-wide: 15,568 out of 94,912
- Since beginning of last month:
- Site-wide: 16,058 out of 94,912
Downloads over time
Distribution of downloads per paper, site-wide
- 18 Dec 2019: We're pleased to announce PanLingua, a new tool that enables you to search for machine-translated bioRxiv preprints using more than 100 different languages.
- 21 May 2019: PLOS Biology has published a community page about Rxivist.org and its design.
- 10 May 2019: The paper analyzing the Rxivist dataset has been published at eLife.
- 1 Mar 2019: We now have summary statistics about bioRxiv downloads and submissions.
- 8 Feb 2019: Data from Altmetric is now available on the Rxivist details page for every preprint. Look for the "donut" under the download metrics.
- 30 Jan 2019: preLights has featured the Rxivist preprint and written about our findings.
- 22 Jan 2019: Nature just published an article about Rxivist and our data.
- 13 Jan 2019: The Rxivist preprint is live!